期刊文献+

RP-HPLC法测定细胞内三磷酸阿糖胞苷浓度 被引量:2

Determination of Intracellular Ara-CTP Level by RP-HPLC
原文传递
导出
摘要 目的:建立一种简单、快速测定细胞内三磷酸阿糖胞苷浓度的反相高效液相色谱法。方法:自全血中分离单个核细胞,离心后进样检测。其中,色谱柱为SymmetryC18,流动相为0.1mol·L-1磷酸二氢钾缓冲液加0.01mol·L-1的四丁基硫酸氢铵(pH2.7),流速为1.0mL·min-1,紫外检测波长为278nm。结果:三磷酸阿糖胞苷检测浓度在0.35~9.12μg·mL-1范围内线性关系良好(r=0.9986),检测限为0.35μg·mL-1;低、中、高浓度的回收率、日内及日间精密度均符合生物样本测定方法学要求。结论:本法简便、快速、稳定、重现性好,适用于细胞内三磷酸阿糖胞苷浓度的监测。 OBJECTIVE: To establish a simple and rapid ion pair RP HPLC method for the determination of intracellular concentration of ara CTP. METHODS: Mononuclearcells were separated from the whole blood, centrifugated and injected for determination on Symmetry C18 column with the mobile phase consisted of 0.1 mol · L ^-1 KDP buffer solution and 0.01 mol · L ^-1 tetrabutylammonium hydrogen sulfate (pH = 2.7) at a flow rate of 1.0 mL · min ^-1 with the UV wavelength set at 278 nm. RESULTS: The linear range of ara - CTP was 0.35 - 9.12 μg · mL ^-1( r = 0. 998 6) with its detection limit at 0.35 μg · mL ^-1. The recoveries of ara -CTP at low, middle and high concentrations, and the intra day and interday RSDs were all up to the standards. CONCLUSION: The established method is simple, rapid, stable, reproducible and applicable for the monitoring of intracellular concentration of ara -CTP.
出处 《中国药房》 CAS CSCD 北大核心 2009年第8期586-588,共3页 China Pharmacy
关键词 反相高效液相色谱法 三磷酸阿糖胞苷 细胞内药物浓度 RP - HPLC Ara - CTP Intracellular drug concentration
  • 相关文献

参考文献2

  • 1李威,谢晓恬.阿糖胞苷耐药代谢酶及相关耐药基因研究进展[J].中国小儿血液与肿瘤杂志,2007,12(4):185-188. 被引量:4
  • 2Boos J .Asimple isocratic ion- pair high performance liquid chromatographic determination of 1 - γ - D - arabinofuranosylcytosine- 5' - triphosphate for intra- cellular drug- monitoring and in vitro incubation assays[J ] .Journal of Pharmaceutical & Biomedical Analysis, 1991,9(1) : 47.

二级参考文献15

  • 1李本尚,谢晓恬,廖雪莲,李莉,石苇,付晓燕,梅竹.阿糖胞苷体外对人白血病细胞株HL-60细胞增殖抑制和诱导凋亡的相关性研究[J].中国小儿血液,2004,9(3):103-107. 被引量:6
  • 2Van Den HE.Absence of mutations in the deoxycytidine kinase gene in patients with relapsed and /or refractory acute myetoid leukemia.Leukemia,2001;15:855.
  • 3Veuger MJ,Honders MW,Spoelder HE,et al.Inactivation of deoxycytidine kinase and overexpression of P-glycoprotein in Ara-C and daunorubicin double resistant leukemic cell lines.Leuk Res,2003;27(5):445-453.
  • 4Carlos Maria Galmarini,Emeline Cros,Kathryn Graham,et al.5' -(3')-nucleotidase mRNA levels in blast cells are a prognostic factor in acute myeloid leukemia patients treated with cyttarabine.Haematologica,2004;89:617-619.
  • 5Galmarini CM,Cros E,Thomas X,et al.The prognostic value of cN-Ⅱ and cN-Ⅲ enzymes in adult acute myeloid leukemia.Haematologica,2005;90:1699-1701.
  • 6Amici A,Magni G.Human erythrocyte pyrimidine 5'-nucleotidase,PN-I.Arch Biochem Biophys,2002;397:184-190.
  • 7Hubeek I,Stam RW,Peters GJ,et al.The human equilibrative nucleoside transporter 1 mediates in vitro cytarabine sensitivity in childhood acute myeloid leukaemia.Br J Cancer,2005;93:1388-1394.
  • 8Galmarini CM,Thomas X,Calvo F,et al.In vivo mechanisms of resistance to,cytarabine in acute myeloid leukaemia.Br J Haematology,2002;117:860-868.
  • 9Reiman T,Clarke ML,Dabbagh L,et al.Differential expression of human equilibrative nucleoside transporter 1 (hENT1) protein in the Reed-Sternberg cells of Hodgkin's disease.Leuk Lymphoma,2002;43:1435-1440.
  • 10Schroder JK,Kirch C,Flasshove M,et al.Constitutive overexpression of the cytidine deaminase gene confers resistance to cytosine arabinosidein vitro.Leukemia,1996;10:1919-1924.

共引文献3

同被引文献22

  • 1Rustum YM,Ravmakers RA.1-β-Arabinofuranosylcytosine in therapy of leukemia:preclinical and clinical overview.Pharmacol Ther,1992,56:307-321.
  • 2Liliemark JO,Gahrton G,Paul CY,et al.Ara-C in plasma and AraCTP in leukemic cells after subcutaneous injection and continuous intravenous infusion of Ara-C in patients with acute nonlymphoblastic leukemia.Semin Oncol,1987,14:167-171.
  • 3Hiddemann W,Schleyer E,Unterhalt M,et al.Optimizing therapy for acute myeloid leukemia based on differences in intracellular metabolism of cytosine arabinoside between leukemic blasts and normal mononuclear blood cells.Therapeutic Drug Monitoring,1996,18:341-349.
  • 4Liliemark JO,Paul CY,Gahrton CG,et al.Pharmacokinetics of 1-β-D-arabinofuranosylcytosine-5'-triphosphate in leukemic cells after intravenous and subcutaneous administration of 1-β-D-arabinofuranosylcytosine.Cancer Res,1985,45:2373-2375.
  • 5Boos J,Hohenlochter B,Schulzewesthoff P,et al.Intracellular retention of cytosine-arabinoside triphosphate in blast cells from children with acute myelogenous and lymphoblastic leukaemia.Med Ped Oncol,1996,26:397-404.
  • 6Heinemann V,Estey E,Keating MJ,et al.Patient-specific dose rate for continuous infusion high-dose cytarabine in relapsed acute myelogenous leukemia.J Clin Oncol,1989,7:622-628.
  • 7Crisp LB,Smith SM,Mathers MA,et al.Effects of cytosine arabinoside on human leukemia cells.Int J Biochem Cell Bilo,1996,28:1061-1069.
  • 8Schleyer E.Detection and separation of intracellular 1-β-D-arabinofuranosyl cytosine -5'-triphosphate by ion pair high performance liquid chromatography.J Chromatography,1989,497:109-120.
  • 9Boos J.A simple isocratic ion-pair high-performance liquid chromatographic determination of 1-β-D-arabinofuranosylcytosine -5'-triphosphate for intracellular drug-monitoring and in vitro incubation assays.J Pharmac & Biome Analy,1991,9:47-52.
  • 10Yamauchi T,Ueda T,Nakamura T.A new sensitive method for determination of intracellular 1-bata-D-Arabinofuranosylcytosine 5'-triphosphate content in human material in vivo.Cancer Res,1996,56:1800-1804.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部